DE602007007320D1 - Pharmazeutische zusammensetzung mit tetrahydrolipstatin - Google Patents

Pharmazeutische zusammensetzung mit tetrahydrolipstatin

Info

Publication number
DE602007007320D1
DE602007007320D1 DE602007007320T DE602007007320T DE602007007320D1 DE 602007007320 D1 DE602007007320 D1 DE 602007007320D1 DE 602007007320 T DE602007007320 T DE 602007007320T DE 602007007320 T DE602007007320 T DE 602007007320T DE 602007007320 D1 DE602007007320 D1 DE 602007007320D1
Authority
DE
Germany
Prior art keywords
tetrahydrolipstatin
pharmaceutical composition
carrageenan
pharmaceutically acceptable
solid dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007007320T
Other languages
English (en)
Inventor
Ljubin Tijana Stanic
Peterka Tanja Rozman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lek Pharmaceuticals dd
Original Assignee
Lek Pharmaceuticals dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals dd filed Critical Lek Pharmaceuticals dd
Publication of DE602007007320D1 publication Critical patent/DE602007007320D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602007007320T 2006-06-27 2007-06-25 Pharmazeutische zusammensetzung mit tetrahydrolipstatin Active DE602007007320D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06013188A EP1872777A1 (de) 2006-06-27 2006-06-27 Pharmazeutische Zusammensetzung enthaltend Tetrahydrolipstatin
PCT/EP2007/005598 WO2008000420A1 (en) 2006-06-27 2007-06-25 Pharmaceutical composition comprising tetrahydrolipstatin

Publications (1)

Publication Number Publication Date
DE602007007320D1 true DE602007007320D1 (de) 2010-08-05

Family

ID=37142317

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007007320T Active DE602007007320D1 (de) 2006-06-27 2007-06-25 Pharmazeutische zusammensetzung mit tetrahydrolipstatin

Country Status (7)

Country Link
EP (2) EP1872777A1 (de)
AT (1) ATE471712T1 (de)
BR (1) BRPI0713062A2 (de)
CA (1) CA2656069A1 (de)
DE (1) DE602007007320D1 (de)
SI (1) SI2023901T1 (de)
WO (1) WO2008000420A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101833250B1 (ko) 2010-10-25 2018-03-02 한미사이언스 주식회사 저융점 활성 성분을 포함하는 구형 압출과립, 이를 포함하는 경구 투여용 정제 및 이의 제조 방법
EP3233066B1 (de) 2014-12-17 2021-11-10 Empros Pharma AB Modifizierte freigabezusammensetzung von orlistat und acarbose zur behandlung von adipositas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
AU8184601A (en) * 2000-06-27 2002-01-08 Hoffmann La Roche Method for preparing a composition
US20030027786A1 (en) * 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition

Also Published As

Publication number Publication date
EP1872777A1 (de) 2008-01-02
ATE471712T1 (de) 2010-07-15
EP2023901B1 (de) 2010-06-23
WO2008000420A1 (en) 2008-01-03
SI2023901T1 (sl) 2011-02-28
CA2656069A1 (en) 2008-01-03
BRPI0713062A2 (pt) 2012-04-10
EP2023901A1 (de) 2009-02-18

Similar Documents

Publication Publication Date Title
WO2007016563A3 (en) Alcohol resistant pharmaceutical formulations
ATE458486T1 (de) Feste, oral applizierbare pharmazeutische darreichungsformen enthaltend rivaroxaban mit modifizierter freisetzung
EA200801926A1 (ru) Таблетки парацетамола с быстрым высвобождением
TW200744677A (en) Compositions and methods for preparation of poorly water soluble drugs with increased stability
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
CL2011000170A1 (es) Composicion farmaceutica solida y estabilizada que comprende un ingrediente farmaceuticamente activo, oxido de titanio y un plastificante; procedimiento para estabilizar la composicion farmaceutica durante una irradiacion luminosa.
EA201100958A1 (ru) Фармацевтическая пероральная дозированная лекарственная форма на основе ингибиторов dpp iv
CY1112320T1 (el) Τιτλοδοτηση της ταπενταδολης
DK1256343T3 (da) Flibanserin til behandlingen af extrapyramidale bevægelseslidelser
EA201290833A1 (ru) Применение амисульприда в качестве противорвотного средства
BRPI1009392A2 (pt) "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
EA201270087A1 (ru) Твердые фармацевтические композиции с фиксированной дозой, содержащие ирбесартан и амлодипин, их получение и их терапевтическое применение
DE602005027469D1 (de) Pharmazeutische zusammensetzung mit verzögerter freisetzung aus tolterodin
WO2012085249A3 (en) Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts together with an organic acid
DE60205905D1 (de) Pharmazeutische zusammensetzung zur orale verabreichung mit verbesserter bioverfügbarkeit
EA200900259A1 (ru) Лечение ревматоидного заболевания глюкокортикоидами с отсроченным высвобождением
BRPI0510820A (pt) composição farmacêutica, forma unitária de dosagem e seus usos
DE602007007320D1 (de) Pharmazeutische zusammensetzung mit tetrahydrolipstatin
ATE460934T1 (de) Pharmazeutische zubereitungen von ciprofloxacin
EA201290378A1 (ru) Композиции, содержащие нестероидные противовоспалительные лекарственные средства
EA201100104A1 (ru) Фармацевтическая композиция, содержащая статин
SE0000303D0 (sv) Novel compounds
ATE479428T1 (de) Olanzapin enthaltende pharmazeutische zusammensetzung
PL378106A1 (pl) Sposób wytwarzania zawierającej fibrat kompozycji farmaceutycznej w postaci tabletek oraz tabletki otrzymane tym sposobem
MX2010008285A (es) Forma galenica para la administracion de triptanos por via trans-mucosa bucal.

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN